In recent years, psychedelics have been gaining popularity when it comes to treating an array of mental health issues. With its promising medical and therapeutic benefits, psychedelic-assisted psychotherapy (PAP) is generating significant interest among policymakers, medical professionals, and the public. As it provides an alternative treatment for refractory mental health concerns, several cities in the U.S are starting to decriminalize some psychedelics.
The current COVID-19 pandemic has created unprecedented challenges for health care providers and their business associates. This public health emergency has changed the way health care providers operate and deliver health care, including the increasing reliance on telehealth. Privacy officers for covered entities and their business associates need to keep abreast of notices and guidances issued by Department of Health and Human Services regarding compliance with Health Insurance Portability and Accountability Act (HIPAA) during this public health emergency.
The COVID-19 pandemic has posed unique risks and challenges in almost all sectors around the globe, including the healthcare industry. Because of this, changes in the way that healthcare is delivered have also been significantly evident.
The security risk analysis and management obligations required by the Health Insurance Portability and Accountability Act (HIPAA) Security Rule are intended to play a crucial role in mitigating risks and vulnerabilities to the security and confidentiality of patient protected health information (PHI). Organizations that fail to implement these measures may be more susceptible to potential PHI breaches and could be confronted with costly regulatory fines.
